These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 9210004)
1. Comparison of colloidal bismuth subcitrate and metronidazole, both in combination with an H2-antagonist as therapy for Helicobacter pylori. Baffone W; Belbusti F; Barbieri E; Pianetti A; Bruscolini F; Fabi MT; Salvaggio L; Albano A J Chemother; 1997 Jun; 9(3):208-12. PubMed ID: 9210004 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. Park KN; Hahm JS; Kim HJ Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924 [TBL] [Abstract][Full Text] [Related]
3. Low dose, short duration therapy for the eradication of Helicobacter pylori in patients with duodenal ulcer. Iser JH; Buttigieg RJ; Iseli A Med J Aust; 1994 Feb; 160(4):192-6. PubMed ID: 7906009 [TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori. Laine L; Estrada R; Trujillo M; Emami S Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755 [TBL] [Abstract][Full Text] [Related]
5. [Influence of colloidal bismuth subcitrate, metronidazole, and amoxycillin on Helicobacter pylori and gastroduodenal ulcer healing]. Quintero M; Moderos I; Buesa F; Gonzalez Cansino R; Haedo W G E N; 1995; 49(2):116-22. PubMed ID: 8566682 [TBL] [Abstract][Full Text] [Related]
6. Colloidal bismuth subcitrate, ranitidine, and ranitidine plus metronidazole in the treatment of duodenal ulcer and Helicobacter pylori infection: a controlled and prospective study. Huang CK; Chen GH Zhonghua Yi Xue Za Zhi (Taipei); 1993 Jul; 52(1):15-20. PubMed ID: 8364776 [TBL] [Abstract][Full Text] [Related]
8. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain). Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584 [TBL] [Abstract][Full Text] [Related]
9. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial. Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657 [TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of two rescue therapies for Helicobacter pylori infection. Wu DC; Hsu PI; Chen A; Lai KH; Tsay FW; Wu CJ; Lo GH; Wu JY; Wu IC; Wang WM; Tseng HH Eur J Clin Invest; 2006 Nov; 36(11):803-9. PubMed ID: 17032348 [TBL] [Abstract][Full Text] [Related]
11. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy. de Boer WA; Haeck PW; Otten MH; Mulder CJ Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338 [TBL] [Abstract][Full Text] [Related]
12. Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: a multicenter, prospective, randomized, controlled study of efficacy and side effects. Thijs JC; van Zwet AA; Moolenaar W; Wolfhagen MJ; ten Bokkel Huinink J Am J Gastroenterol; 1996 Jan; 91(1):93-7. PubMed ID: 8561152 [TBL] [Abstract][Full Text] [Related]
13. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication. Avidan B; Melzer E; Keller N; Bar-Meir S Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370 [TBL] [Abstract][Full Text] [Related]
14. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection. Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805 [TBL] [Abstract][Full Text] [Related]
15. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication. Tepes B; Kavcic B; Gubina M; Krizman I Hepatogastroenterology; 1999; 46(27):1746-50. PubMed ID: 10430336 [TBL] [Abstract][Full Text] [Related]
16. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study. Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114 [TBL] [Abstract][Full Text] [Related]
17. Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection. Dore MP; Graham DY; Mele R; Marras L; Nieddu S; Manca A; Realdi G Am J Gastroenterol; 2002 Apr; 97(4):857-60. PubMed ID: 12003419 [TBL] [Abstract][Full Text] [Related]
18. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. Sung JJ; Chung SC; Ling TK; Yung MY; Leung VK; Ng EK; Li MK; Cheng AF; Li AK N Engl J Med; 1995 Jan; 332(3):139-42. PubMed ID: 7800005 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection. Tucci A; Poli L; Gasperoni S; Varoli O; Paparo GF; De Giorgio R; Stanghellini V; Corinaldesi R Ital J Gastroenterol; 1994 Apr; 26(3):107-10. PubMed ID: 8061335 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of a new bismuth-free triple therapy in nude mice and humans. Karita M; Tsuda M; Okita K; Sugiyama T; Nakazawa T Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S31-4. PubMed ID: 8574732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]